<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04627480</url>
  </required_header>
  <id_info>
    <org_study_id>2513</org_study_id>
    <nct_id>NCT04627480</nct_id>
  </id_info>
  <brief_title>Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial</brief_title>
  <official_title>Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ProofPilot</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fisher Wallace</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ProofPilot</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator&#xD;
      Device (CES) for the treatment of insomnia characterized by difficulties with sleep&#xD;
      maintenance using a 20-minute treatment right before bedtime.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">February 21, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>Sham Device</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in total sleep per night at week 4 between active and sham arm</measure>
    <time_frame>baseline versus week 4</time_frame>
    <description>Measured by Fitbit Charge 4 connected health device work on the wrist</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Device Tolerance and Safety measured by SAFTEE</measure>
    <time_frame>4 weeks from baseline</time_frame>
    <description>assessment of safety and adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in WASO (wake after sleep onset) between sham versus active arms</measure>
    <time_frame>baseline versus week 4</time_frame>
    <description>measured by Fitbit Charge 4 connected health device worn on the wrist</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Insomnia Severity between Sham versus active arms</measure>
    <time_frame>baseline versus week 4</time_frame>
    <description>measured by the self report Insomnia Severity Index (ISI)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Insomnia</condition>
  <condition>Insomnia Chronic</condition>
  <condition>Sleep</condition>
  <arm_group>
    <arm_group_label>Experiment Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active Fisher Wallace device for full 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Arm</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham Fisher Wallace device for 4 weeks, then cross over at 4 weeks to active device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fisher Wallace Neurostimulation Device</intervention_name>
    <description>a Cranial Electrotherapy Stimulator Device (CES).</description>
    <arm_group_label>Experiment Arm</arm_group_label>
    <arm_group_label>Sham Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Age greater than or equal to 21 US resident Can receive packages to their home via&#xD;
        UPS/Fedex/USPS Read/write English Insomnia Severity Index Score Greater than 14 Diagnosis&#xD;
        of insomnia by a medical physician Subjects with a Generalized Anxiety Diagnosis will be&#xD;
        excluded Have not contemplated suicide in the past year Not been institutionalized for&#xD;
        mental health issues. Not currently being treated for or suspect a mental health issue Not&#xD;
        currently experiencing problems with alcohol or drug abuse Can commit to not drinking&#xD;
        alcohol 4 hours before bedtime for the duration of the study Not taking medications&#xD;
        affecting the nervous system (e.g. psychiatric medications) Not taking hypnotics or any&#xD;
        sleep aid or marijuana (in any form) Can commit to one (1) 20 minute session per day for 8&#xD;
        weeks Has not used a brain stimulation treatment in one year No suspected or known history&#xD;
        of heart disease No pacemaker, or any form of medical electronics, including but not&#xD;
        limited to a deep brain stimulator, electronic stent, etc.&#xD;
&#xD;
        Not under medical supervision for other serious medical condition Not taking opioids No&#xD;
        pain or headaches that interrupt sleep Not participating in any other sleep study Not&#xD;
        experiencing restless leg syndrome No Nickel Allergy No Sleep Apena as measured by&#xD;
        STOP-Bang Assessment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>ProofPilot (Remote Virtual Trial)</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 9, 2020</study_first_submitted>
  <study_first_submitted_qc>November 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2020</study_first_posted>
  <last_update_submitted>January 13, 2021</last_update_submitted>
  <last_update_submitted_qc>January 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

